BSE NSE
Your Result on : IPO Synopsis
Senores Pharmaceuticals Ltd
Registered Office: #.1101-1103 11th Flr South Twr,Ambali Bopal Road, Ahmedabad - 380054, Gujarat, India.
Phone : +91-79-2999 9857   Fax:
Email :  cs@senorespharma.com  
Website :  www.senorespharma.com
Initial public offering of 14,887,723 equity shares of face value of (Rs) 10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of (Rs) 391 per equity share (including a share premium of (Rs) 381 per equity share) ("Offer Price") aggregating to (Rs) 582.11 crores (the "Offer"). The offer comprises of a fresh issue of 12,787,723 equity shares by the company aggregating to (Rs) 500.00 crores (the "Fresh Issue") and an offer for sale of 2,100,000 equity shares (the "Offered Shares") aggregating to (Rs) 82.11 crores (the "Offer for Sale"), comprising 250,000 equity shares aggregating to (Rs) 9.78 crores by Swapnil Jatinbhai Shah, 550,000 equity shares aggregating to (Rs) 21.51 crores by Ashokkumar Vijaysinh Barot, 300,000 equity shares aggregating to (Rs) 11.73 crores by Sangeeta Mukur Barot and 1,000,000 equity shares aggregating to (Rs) 39.10 crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute 32.33 % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of 75,000 equity shares, aggregating to (Rs) 2.93 crores constituting 0.16% of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The face value of the equity shares is (Rs) 10 each and the offer price is 39.10 times the face value of the equity shares.
Issue Money Payable On
Opens On Closes On Application Allotment
20-Dec-24 24-Dec-24 391.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 38   Further Multiples of : 38
  (Rs.Cr) Lead Managers to the Issue
Project Cost 457.81 Ambit Pvt Ltd
Project Financed through Current Offer 582.11  
Post Issue Equity Share Capital 46.05  
Issue Price 391.00  
Projects
Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta Facility Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSI
Funding the working capital requirements of the company and its subsidiary namely SPI ad Ratnatris Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes
Investment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries Investment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements
Promoted By
Swapnil Jatinbhai
Ashokkumar Vijaysingh Barot
Anar Swapnil Shah
Listing At
BSE
NSE
Registrar to the Issue
No Data Available
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)